Based on cell and animal experiments, we concluded that KNTC1 can enhance the invasion, migration, and tumorigenicity of tumor cells via MMP2 and MMP9, providing a basis for the subsequent study of KNTC1 as a target for cervical cancer treatment. This evidence concerns the gene KNTC1 and cervical cancer.